Fosun Pharma USA Announces Abstract to be Presented at IASLC

/PRNewswire/ -- Fosun Pharma USA Inc. ("Fosun Pharma USA") announced today its abstract on ASTRIDE (NCT05468489), a phase 3 randomized, open-label study of...

Related Keywords

Chicago , Illinois , United States , Shanghai , China , New Jersey , Chinese , Stan Lechpammer , Lucia Allen Chau , Fosun Pharmaceutical Group Co Ltd , Public Relations Communications , Prnewswire Fosun Pharma United States Inc , Fosun Pharma United States Inc , Fosun Pharma Group , Drug Administration Serplulimab , Shanghai Henlius Biotech Inc , Linkedin , Pharma United States , Pharma United , International Association , Lung Cancer , America Conference , Vice President , Medical Affairs , Innovative Medicines , Fosun Pharma United , Drug Administration , Henlius Biotech , Fosun Pharma United States , Fosun Pharma , Fosun Pharmaceutical , Pharma United States Contacts , Public Relations ,